Patient Group Direction: ciprofloxacin 500mg (anthrax)

Document first published:
Page updated:
Topic:
,
Publication type:

Patient Group Direction (PGD) for the initial supply of ciprofloxacin 500mg tablets to adults and children aged 12 years and over with known or suspected exposure to anthrax.

Document

Patient Group Direction: ciprofloxacin 500mg (anthrax)

Patient Group Direction: ciprofloxacin 500mg (anthrax)

  • Microsoft Word
  • 154 KB
  • 15 pages

Summary

Updated April 2025.